Stay updated on Nivolumab Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ibrutinib in CLL Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page. There are no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:20:32.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Texas as a study site. The previous Texas Locations entry was removed and the page revision updated to v3.3.3 (HHS Vulnerability Disclosure link removed).
    Difference
    0.2%
    Check dated 2025-12-23T20:43:56.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The Publications section now displays auto-filled PubMed notes and includes a new revision label (v3.3.2). The older PubMed-source description was removed and replaced with the updated revision tag (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-25T10:24:56.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page no longer displays a notice about government funding and NIH operations status, which was a meta-information banner rather than core study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:47:47.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    No notable changes detected; the page content and layout remain focused on the NCT02420912 study details.
    Difference
    0.4%
    Check dated 2025-11-03T20:41:23.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Page now includes a government funding status notice and new version v3.2.0; a disease term (B-cell chronic lymphocytic leukemia) was removed.
    Difference
    3%
    Check dated 2025-10-06T04:45:07.000Z thumbnail image

Stay in the know with updates to Nivolumab Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.